These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1495887)
1. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Chavany C; Le Doan T; Couvreur P; Puisieux F; Hélène C Pharm Res; 1992 Apr; 9(4):441-9. PubMed ID: 1495887 [TBL] [Abstract][Full Text] [Related]
2. Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides. Zobel HP; Kreuter J; Werner D; Noe CR; Kümel G; Zimmer A Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):483-93. PubMed ID: 9361907 [TBL] [Abstract][Full Text] [Related]
3. Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake. Chavany C; Saison-Behmoaras T; Le Doan T; Puisieux F; Couvreur P; Hélène C Pharm Res; 1994 Sep; 11(9):1370-8. PubMed ID: 7816773 [TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Zimmer A Methods; 1999 Jul; 18(3):286-95, 322. PubMed ID: 10454987 [TBL] [Abstract][Full Text] [Related]
5. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. Fattal E; Vauthier C; Aynie I; Nakada Y; Lambert G; Malvy C; Couvreur P J Control Release; 1998 Apr; 53(1-3):137-43. PubMed ID: 9741921 [TBL] [Abstract][Full Text] [Related]
6. Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells. Lambert G; Fattal E; Brehier A; Feger J; Couvreur P Biochimie; 1998 Dec; 80(12):969-76. PubMed ID: 9924975 [TBL] [Abstract][Full Text] [Related]
7. Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles. Zobel HP; Junghans M; Maienschein V; Werner D; Gilbert M; Zimmermann H; Noe C; Kreuter J; Zimmer A Eur J Pharm Biopharm; 2000 May; 49(3):203-10. PubMed ID: 10799810 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate systems for the delivery of antisense oligonucleotides. Lambert G; Fattal E; Couvreur P Adv Drug Deliv Rev; 2001 Mar; 47(1):99-112. PubMed ID: 11251248 [TBL] [Abstract][Full Text] [Related]
9. An approach for new anticancer drugs: oncogene-targeted antisense DNA. Schwab G; Duroux I; Chavany C; Hélène C; Saison-Behmoaras E Ann Oncol; 1994; 5 Suppl 4():55-8. PubMed ID: 8060898 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles. Zobel HP; Stieneker F; Atmaca-Abdel Aziz S; Gilbert M; Werner D; Noe CR; Kreuter J; Zimmer A Eur J Pharm Biopharm; 1999 Jul; 48(1):1-12. PubMed ID: 10477322 [TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Schwab G; Chavany C; Duroux I; Goubin G; Lebeau J; Hélène C; Saison-Behmoaras T Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10460-4. PubMed ID: 7937975 [TBL] [Abstract][Full Text] [Related]
12. Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes. Zobel HP; Werner D; Gilbert M; Noe CR; Stieneker F; Kreuter J; Zimmer A J Microencapsul; 1999; 16(4):501-9. PubMed ID: 10420334 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles. Couvreur P; Kante B; Lenaerts V; Scailteur V; Roland M; Speiser P J Pharm Sci; 1980 Feb; 69(2):199-202. PubMed ID: 7359324 [TBL] [Abstract][Full Text] [Related]
14. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123 [TBL] [Abstract][Full Text] [Related]
15. Comparison of antisense oligonucleotide drug delivery systems. Weyermann J; Lochmann D; Zimmer A J Control Release; 2004 Dec; 100(3):411-23. PubMed ID: 15567506 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Nakada Y; Fattal E; Foulquier M; Couvreur P Pharm Res; 1996 Jan; 13(1):38-43. PubMed ID: 8668676 [TBL] [Abstract][Full Text] [Related]
17. Lipid-Albumin Nanoparticles (LAN) for Therapeutic Delivery of Antisense Oligonucleotide against HIF-1α. Li H; Quan J; Zhang M; Yung BC; Cheng X; Liu Y; Lee YB; Ahn CH; Kim DJ; Lee RJ Mol Pharm; 2016 Jul; 13(7):2555-62. PubMed ID: 27253378 [TBL] [Abstract][Full Text] [Related]
18. Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex. Berton M; Allémann E; Stein CA; Gurny R Eur J Pharm Sci; 1999 Dec; 9(2):163-70. PubMed ID: 10620729 [TBL] [Abstract][Full Text] [Related]